Medication-Imposed Functional Limitations as Employment Evidence in PI Cases

Amar Lunagaria — Co-Founder & Chief Pharmacist, LienScripts | March 4, 2026 | 8 min read

Many injury medications carry FDA-documented warnings against driving, operating machinery, or performing safety-sensitive work. These pharmacological restrictions create objectively documented functional limitations that support lost wages and earning capacity claims.

The medications prescribed after a personal injury impose functional limitations that are documented by the FDA, printed on every prescription label, and recorded in the pharmacy dispensing system. Warnings against driving, operating heavy machinery, making critical decisions, or performing safety-sensitive tasks are not subjective complaints from the plaintiff -- they are pharmacological facts established by clinical trials and regulatory review. When a plaintiff takes opioids, benzodiazepines, muscle relaxants, or sedating anticonvulsants, the medications themselves restrict what the plaintiff can safely do, creating objectively documented functional limitations that directly support lost wages and diminished earning capacity claims.

• FDA-mandated medication warnings against driving, operating machinery, and safety-sensitive work are objective functional limitations documented on every prescription label
• The pharmacy dispensing system records every medication with these warnings, creating a timestamped record of when the plaintiff was pharmacologically restricted from full employment
• LienScripts identifies every functional limitation associated with the plaintiff's medication regimen, and each case receives a MERIT (Medication Evaluation & Rationale for Injury Treatment) report that maps medications to their employment-related restrictions
• Multiple sedating medications taken concurrently amplify functional limitations beyond what any single medication would impose
• These limitations exist independently of the plaintiff's subjective symptoms -- even a plaintiff who reports feeling fine is pharmacologically restricted by the medications they take

FDA-Documented Employment Restrictions by Drug Class

Opioid Analgesics

All opioid medications carry warnings that they may cause:

• Drowsiness and sedation
• Impaired coordination and reaction time
• Cognitive impairment affecting judgment and decision-making
• Risk of falls

Employment impact: Opioid-treated patients cannot safely drive commercial vehicles, operate heavy machinery, work at heights, or perform tasks requiring sustained concentration and rapid response time.

Muscle Relaxants

Muscle relaxants including cyclobenzaprine, tizanidine, and methocarbamol carry warnings for:

• Significant drowsiness (especially during the first weeks of treatment)
• Dizziness and impaired coordination
• Blurred vision
• Cognitive fog

Employment impact: These medications restrict the plaintiff from any position requiring alertness, coordination, or visual acuity during working hours.

Benzodiazepines and Anxiolytics

Medications prescribed for post-accident anxiety and PTSD carry some of the most restrictive warnings:

• Pronounced sedation
• Significant cognitive impairment
• Impaired motor coordination
• Memory impairment

Employment impact: Benzodiazepine-treated patients face restrictions on virtually all safety-sensitive employment and many cognitively demanding positions.

Anticonvulsants Used for Pain

Gabapentin and pregabalin, commonly prescribed for neuropathic pain, carry warnings for:

• Dizziness
• Drowsiness
• Difficulty concentrating
• Peripheral edema affecting mobility

Employment impact: These medications restrict driving, operating machinery, and tasks requiring sustained mental focus.

As Amar Lunagaria, PharmD, LienScripts' Chief Pharmacist explains, "When I review a plaintiff's medication regimen and see an opioid, a muscle relaxant, and gabapentin taken concurrently, I am looking at three medications that each independently restrict driving and operating machinery. Together, their sedative effects are additive or synergistic. The plaintiff is not choosing to avoid work -- their medication regimen makes it pharmacologically unsafe for them to perform most jobs that require alertness, coordination, or safety-sensitive tasks. These are not subjective claims; they are printed on the prescription label and documented in every pharmacy reference."

Quantifying the Functional Limitation Period

The pharmacy dispensing record provides the exact dates during which each limiting medication was active:

• Start date -- the date the first sedating medication was dispensed
• Duration -- the continuous period over which limiting medications were dispensed
• Overlap periods -- dates when multiple sedating medications were taken concurrently (amplified limitations)
• End date -- the date the last limiting medication was discontinued (if applicable)

This timeline provides a mathematically verifiable period during which the plaintiff was under pharmacological restrictions that affected their ability to work. The period is not based on the plaintiff's testimony -- it is derived from dispensing timestamps in the pharmacy system.

Additive and Synergistic Sedation

When a plaintiff takes multiple sedating medications simultaneously, the functional limitations are amplified:

• Additive effect -- two sedating medications produce combined sedation greater than either alone
• Synergistic effect -- certain drug combinations produce sedation significantly greater than the sum of the individual effects (e.g., opioids combined with benzodiazepines)

The pharmacy record documents every overlapping sedating medication with exact fill dates, creating an objective map of periods when the plaintiff was under maximum pharmacological restriction.

Using Medication Limitations in Damages Analysis

When presenting medication-based functional limitation evidence in demand packages:

1. List every medication with employment-related warnings -- include the specific FDA warning language
2. Create a medication limitation timeline -- show the exact dates during which each limiting medication was active
3. Identify overlap periods -- highlight when multiple limiting medications were taken concurrently
4. Map limitations to the plaintiff's occupation -- show how specific medication warnings directly prevent the plaintiff from performing their job duties
5. Calculate the limitation period -- total the days/months during which pharmacological restrictions were active

LienScripts generates a MERIT (Medication Evaluation & Rationale for Injury Treatment) report for every case, providing pharmacist-signed documentation for demand packages that includes functional limitation analysis based on the medication regimen.

Occupation-Specific Analysis

The impact of medication restrictions varies by occupation:

• Commercial drivers -- any sedating medication renders the plaintiff unable to hold a CDL or drive commercially (DOT regulations)
• Construction workers -- medications impairing coordination, balance, or alertness eliminate the ability to work at heights or with heavy equipment
• Healthcare workers -- cognitive impairment from medications may prevent clinical decision-making responsibilities
• Office workers -- even desk jobs are affected by medications causing cognitive fog, impaired concentration, or excessive drowsiness

The plaintiff's specific occupation determines the evidentiary weight of each medication restriction. A truck driver on opioids has a total employment restriction; an office worker on the same medication may have a partial restriction.

Countering Defense Arguments

"The plaintiff could work a sedentary job."

Many sedating medications impair cognitive function, not just physical function. A sedentary job requiring sustained concentration, accurate data entry, or critical decision-making is still affected by opioid-induced cognitive impairment, benzodiazepine-related memory problems, or anticonvulsant-caused difficulty concentrating. The medication warnings do not distinguish between physical and cognitive impairment.

"The plaintiff is exaggerating the medication's effects."

The functional limitations are documented by the FDA, not reported by the plaintiff. Clinical trials conducted by the pharmaceutical manufacturer established these effects before the drug reached the market. The warnings are printed on the prescription label regardless of whether the individual plaintiff feels impaired.

"The plaintiff could time their medications around work."

Many injury medications require around-the-clock dosing (Q6H, Q8H) to maintain therapeutic levels. Skipping doses during work hours would cause symptom breakthrough and is medically inadvisable. The prescribed dosing schedule, documented in the pharmacy SIG codes, shows that medication effects span the entire waking day.

Practical Takeaways

Medication-imposed functional limitations are among the most objective and defensible elements of a lost wages or earning capacity claim. They are documented by the FDA, printed on prescription labels, recorded in pharmacy dispensing systems, and based on clinical trial data rather than patient self-report. Attorneys who present medication-based functional limitation analysis transform the pharmacy record into quantifiable employment evidence that directly supports the damages calculation.

Related Resources

• Polypharmacy Burden as a Damages Element -- How multi-medication regimens amplify damages
• Medication Side Effects as Secondary Damages -- Side effects extending the damages scope
• Co-Prescribed Medications Prove Injury Severity -- Multi-medication severity evidence